Both in Pharmaceuticals
Marker Therapeutics vs Pasithea Therapeutics
Over the past year MRKR returned −6.8% and KTTA returned −43.6%; their daily moves had a correlation of 0.15.
MRKR −6.8% KTTA −43.6%Growth of $1, one year, split-adjusted
| Metric | MRKR | KTTA |
|---|---|---|
| Price | $0.9601 | $0.4049 |
| Market cap | $16.0M | $13.5M |
| Today | −10.27% | −9.05% |
| 1 month | −19.3% | −21.2% |
| 6 months | −31.4% | −41.3% |
| Year to date | −35.6% | −68.6% |
| 1 year | −3.3% | −43.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 6.9× | — |
| Net cash | $11.3M | $45.7M |
| Dividend yield | — | — |
| Volatility (60d) | 83.0% | 77.7% |
| Short % of float | 1.3% | 0.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).